🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1265
-0.0125 (-8.99%)
At close: Nov 20, 2026

Northwest Biotherapeutics Statistics

Total Valuation

NWBO has a market cap or net worth of 225.72 million. The enterprise value is 305.23 million.

Market Cap225.72M
Enterprise Value 305.23M

Important Dates

The next estimated earnings date is Tuesday, March 16, 2027.

Earnings Date Mar 16, 2027
Ex-Dividend Date n/a

Share Statistics

NWBO has 1.78 billion shares outstanding. The number of shares has increased by 15.65% in one year.

Current Share Class 1.78B
Shares Outstanding 1.78B
Shares Change (YoY) +15.65%
Shares Change (QoQ) +4.18%
Owned by Insiders (%) 3.93%
Owned by Institutions (%) 0.10%
Float 1.71B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 79.03
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 106.87
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.89

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -76.28%
Return on Invested Capital (ROIC) -1,077.58%
Return on Capital Employed (ROCE) 310.48%
Weighted Average Cost of Capital (WACC) 3.13%
Revenue Per Employee 27,200
Profits Per Employee -387,724
Employee Count105
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax -537,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -46.80% in the last 52 weeks. The beta is -0.62, so NWBO's price volatility has been lower than the market average.

Beta (5Y) -0.62
52-Week Price Change -46.80%
50-Day Moving Average 0.16
200-Day Moving Average 0.19
Relative Strength Index (RSI) 25.48
Average Volume (20 Days) 4,359,144

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NWBO had revenue of 2.86 million and -40.71 million in losses. Loss per share was -0.03.

Revenue2.86M
Gross Profit -17.48M
Operating Income -45.95M
Pretax Income -40.20M
Net Income -40.71M
EBITDA -42.88M
EBIT -45.95M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 725,000 in cash and 69.84 million in debt, with a net cash position of -69.11 million or -0.04 per share.

Cash & Cash Equivalents 725,000
Total Debt 69.84M
Net Cash -69.11M
Net Cash Per Share -0.04
Equity (Book Value) -46.30M
Book Value Per Share -0.03
Working Capital -88.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.20 million and capital expenditures -1.29 million, giving a free cash flow of -44.49 million.

Operating Cash Flow -43.20M
Capital Expenditures -1.29M
Depreciation & Amortization 3.07M
Net Borrowing 33.75M
Free Cash Flow -44.49M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,608.82%
Pretax Margin -1,407.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NWBO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -15.65%
Shareholder Yield -15.65%
Earnings Yield -24.63%
FCF Yield -19.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.

Last Split Date Sep 26, 2012
Split Type Reverse
Split Ratio 0.0625

Scores

Altman Z-Score n/a
Piotroski F-Score 3